Hints and tips:
Related Special Reports
...Adrian van den Hoven, director-general of generic drugmakers association Medicines for Europe, said the body “strongly supports” the move to improve Europe’s medicine supply security in the post-pandemic...
...facing the health service....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...The results focus on the remaining business, focused on innovative drugs, after Novartis spun out its generics division Sandoz this month....
...The Swiss pharmaceuticals group is following many rivals to focus its operations on higher-value innovative treatments rather than the cheaper off-patent drugs made by Sandoz, including generic versions...
...(One day, you never know, the discussion might actually turn to the UK’s crumbling public services and infrastructure.)...
...Brewer sought to expand into healthcare services, which are more lucrative. Walgreens acquired urgent-care provider Summit Health-City MD and post-acute home-care provider CareCentrix....
...A blockbuster drug developed by US pharmaceutical group Merck to treat Covid-19 has been linked to mutations transmitted when the coronavirus spreads between patients, a finding that will increase scrutiny...
...The world’s top global tech and pharmaceutical companies have set up in the country and are major contributors to state coffers via their taxes....
...One example comes from a comparison of the disclosures by WuXi Biologics, a pharmaceutical company that listed in 2017, and WuXi XDC, a unit it spun off and listed last year....
...Under the IRA rules, older drugs can also escape Medicare negotiation if they face generic competition....
...But despite the huge need for new drugs, many pharmaceutical companies have cut investment in antibiotics research....
...The reforms have been fiercely resisted by the pharmaceutical industry, which has warned they would cripple innovation and hinder development of life-saving medicines....
...Several of the world’s biggest pharmaceutical companies are fighting shareholder proposals to force them to disclose information on their use of a controversial patent strategy that can delay rivals from...
...For the GSK legal team, this meant recasting itself to support a smaller, more focused pharmaceutical business....
...The company, whose four approved oncology treatments generated $2bn in sales last year, should help the pharmaceutical company offset some of an expected decline in revenue as the Covid vaccine boom fades...
...The first was EQT’s £4.5bn purchase of Dechra, a UK-based veterinary pharmaceuticals group. The second was Permira’s takeover of clinical testing group Ergomed for £703mn....
...For example: if Generic Greek God Capital is buying Widgetmaker Inc, 70 per cent of the equity it ponies up might come from one of its LBO funds....
...Rather than improving the government’s generic capacity to respond to a civil emergency, Keith told the inquiry, Brexit preparations had diverted attention from pandemic planning by the time coronavirus...
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
...The case is one of many challenges the company has faced to what the Dutch Pharmaceutical Accountability Foundation calls its “goose with golden eggs”....
...Proxy firm Institutional Shareholder Services recommended shareholders vote to replace Thompson with Icahn’s nominee Andrew Teno but vote in favour of deSouza, who is also a director at Disney....
...Generics have been the métier of Teva rather than genetics. It is here that the story starts darkening....
..., that allows UBS clients to access its advisers, mobile banking services, and shared expertise....
International Edition